EGFR and diabetes mellitus: Increased EGFR contributes to insulin resistance and correlates with a higher risk of developing diabetes, and the use of TKI inhibitors in most cases led to an arrest of diabetes development, normalization of glycemia, and in extreme cases even to diabetes re-emission.